75F40123F19054

FY2023 STREAMLINE PROCESSES AND ENHANCE NEW DRUG REVIEW

Food and Drug Administration · United States

This contract has been awarded. Browse open opportunities

View Source

Time Left to Bid

Awarded

AwardedOtherFederal

Basic information

Reference number: 75F40123F19054
Issuing organization: Food and Drug Administration · Find award history →
Government level: Federal
Solicitation type: Other
Title: FY2023 STREAMLINE PROCESSES AND ENHANCE NEW DRUG REVIEW
Source: USASpending (Federal)
Source ID: usa-75F40123F19054

Details

Location: United States

Description

FY2023 STREAMLINE PROCESSES AND ENHANCE NEW DRUG REVIEW Awarded to: EAGLE HILL CONSULTING, LLC Agency: Department of Health and Human Services Sub-agency: Food and Drug Administration Award type: BPA CALL

Dates

Publication: 2023/02/16 12:00:00 AM UTC
Closing date: 2025/06/13 12:00:00 AM UTC

Estimated value

$2.0M USD

Classification

Normalized category

Other

Source: USASpending (Federal)

Last updated 2026-09-02, 1:16:06 a.m.

Data refreshed every 2 hours